All
Research uncovers potential of sulforaphane as therapy for epidermolysis bullosa simplex
January 3rd 2008Washington - Sulforaphane, a natural compound found in broccoli and other cruciferous vegetables, may be effective in helping treat epidermolysis bullosa simplex, according to research presented during the annual meeting of the American Society for Cell Biology, held here recently and reported on by Reuters Health.
Study warns against use of quinapril to treat digital ulcers in cutaneous sclerosis patients
January 3rd 2008Bangor, Wales - British researchers report that quinapril, a long-acting angiotensin-converting enzyme (ACE) inhibitor, does not appear to prevent upper-limb digital ulcers or other vascular manifestations in patients with limited cutaneous systemic sclerosis (lcSSc), reports Reuters Health.
Testing set for ArteFill’s use in treating acne scars
January 3rd 2008St. Petersburg, Fla. - Testing is set to begin on ArteFill (polymethylmethacrylate, Artes Medical) for the treatment of acne scars and other depressed atrophic scars, reports MedicalNewsToday.com. St. Petersburg-based dermatologist James Spencer, M.D., will head the study.
Per agreement with Galderma, Anika reaquires rights to Elevess dermal filler products
January 3rd 2008Bedford, Mass. - Anika Therapeutics, based here, announced that Anika and Galderma have finalized their agreement to terminate all license, development and supply arrangements involving the Elevess family of filler products, reports MedicalNewsToday.com.
Despite contrary report, UK health agency says bath products help in managing eczema
January 3rd 2008London - In the wake of a recent report stating that bath products do little to combat eczema in children, Great Britain’s National Health Service is endorsing such products as being effective in helping to manage the disease, reports BBCNews.
Bristol-Myers Squibb, Medarex set to seek FDA approval for their melanoma drug
January 3rd 2008New York - Bristol-Myers Squibb Co., based here, and Medarex Inc., Princeton, N.J., are reporting mixed results from three studies of the experimental drug ipilimumab for treating advanced melanoma, according to news source Reuters.
‘Sell’ your practice for millions
January 1st 2008Two techniques for selling your practice for millions when you retire are using a nontraditional retirement plan or a captive insurance company to fund a buyout. The key is to plan early. There are no outside buyers of practices willing to pay you millions for your practice anymore. If you want such a buyout, you must plan for it yourself.
Time-tested ingredients, fresh entities provide contemporary therapeutic options
January 1st 2008Several new medications have become available for the treatment of dermatologic disorders in the past year. They include formulations of time-tested ingredients in enhanced vehicles as well as newer entities with safety and/or efficacy advantages.
Derm takes traditionally surgical procedure into the nonsurgical realm
January 1st 2008An unhappy rhinoplasty patient suggested to dermatologist Cameron Rokhsar, M.D., F.A.A.D., F.A.A.C.S., that he use Radiesse, which he was about to inject in her nasolabial folds, to diminish the divots in her nose from a previous rhinoplasty.
Saving for retirement without sacrificing lifestyle
January 1st 2008This is an excellent question because it relates to current lifestyle as well as future planning. You used the word sacrifice and, since you only go around once, why would anyone want to needlessly diminish the quality of life that they could currently enjoy? Your question brings up significant issues, which call into question the very premise of traditional financial planning.